Development of an optimised vaccine formulation to prevent Group A Streptococcus infection

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/jwz9-cx37
Cited by: 0

Fields of Study & Subjects

Streptococcal Infections and Treatments Bacterial Infections and Vaccines Neonatal and Maternal Infections

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN